Test of new HIV drug

A study under way at UAB aims to determine whether the first of a new class of HIV drugs is safe and effective in preventing the virus from entering healthy cells.

The national multi-center study is led by Michael Saag, M.D., professor of medicine and director of UAB's Center for AIDS Research. "Despite impressive advances in the treatment of HIV/AIDS, there is a need for new drugs to treat patients who have developed drug resistance to current therapies.

This new drug, called AMD11070, is one of the more promising ones to make it into clinical trials." More information, including a list of participating sites, is available at http://www.clinicaltrials.gov.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Sweden exceeds UNAIDS HIV goals but faces new challenges